Skip to main content
. Author manuscript; available in PMC: 2019 Mar 26.
Published in final edited form as: Pharmacol Ther. 2016 Aug 7;171:93–103. doi: 10.1016/j.pharmthera.2016.08.003

Table 2.

Summary of pericytes markers.

Surface
marker		 Positive (+), or
negative (−)
expression		 Pericyte reference
CD10 + Crisan et al., 2008
CD13 + Crisan et al., 2008
CD14 − Dar et al., 2012; Zannettino et al., 2007
CD29 + Dar et al., 2012
CD31 − Crisan et al., 2008; Dar et al., 2012; Psaltis, Harbuzariu, Delacroix, Holroyd, & Simari, 2011; Tallone et al., 2011; Zannettino et al., 2007; Zimmerlin, Donnenberg, Rubin, & Donnenberg, 2013
CD34 − Crisan et al., 2008; Psaltis et al., 2010; Tallone et al., 2011; Zimmerlin et al., 2009, 2012
CD44 + Crisan et al., 2008; Dar et al., 2012; Psaltis et al., 2010; Zannettino et al., 2007
CD45 − Crisan et al., 2008; Dar et al., 2012; Psaltis et al., 2010; Zannettino et al., 2007; Zimmerlin et al., 2009, 2012
CD56 − Crisan et al., 2008; Psaltis et al., 2010
CD73 + Crisan et al., 2008; Dar et al., 2012; Psaltis et al., 2010; Zimmerlin et al., 2013
CD90 + Crisan et al., 2008; Dar et al., 2012; Psaltis et al., 2010; Tallone et al., 2011; Zannettino et al., 2007; Zimmerlin et al., 2009, 2013
CD105 + Crisan et al., 2008; Dar et al., 2012; Psaltis et al., 2010; Zannettino et al., 2007
CD106 − Zannettino et al., 2007
CD117 − Zimmerlin et al., 2009
CD133 − Crisan et al., 2008
CD140 + Crisan et al., 2008; Dar et al., 2012; Psaltis et al., 2010; Tallone et al., 2011
CD144 − Crisan et al., 2008
CD146 + Crisan etal., 2008; Dar et al., 2012; Psaltis et al., 2010; Tallone et al., 2011; Zannettino et al., 2007; Zimmerlin et al., 2009, 2013
CD166 + Zannettino et al. (2007)
αSMA + Crisan et al., 2008; Psaltis et al., 2010; Tallone et al., 2011
NG2 + Crisan etal., 2008; Dar et al., 2012; Psaltis et al., 2010; Tallone et al., 2011
STRO-1 + Psaltis et al., 2010; Zannettino et al., 2007